Scilex Holding (SCLXW) FCF Margin (QoQ) (2022 - 2026)
Scilex Holding (SCLXW) FCF Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Scilex Holding | - | - | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,144.00 |
| Dec 31, 2025 | -43,850.00 |
| Sep 30, 2025 | 585.00 |
| Jun 30, 2025 | -4,846.00 |
| Mar 31, 2025 | 10,313.00 |
| Dec 31, 2024 | -1,841.00 |
| Sep 30, 2024 | 2,130.00 |
| Jun 30, 2024 | -7,217.00 |
| Mar 31, 2024 | 12,633.00 |
| Dec 31, 2023 | -9,816.00 |
| Sep 30, 2023 | 16,519.00 |
| Jun 30, 2023 | -3,390.00 |
| Mar 31, 2023 | -6,710.00 |
| Dec 31, 2022 | -2,829.00 |
| Sep 30, 2022 | 17,783.00 |
| Jun 30, 2022 | 190.00 |